NAMWISE project aims to drive the adoption and integration of New Approach Methodologies (NAMs) for the assessment of the safety and efficacy of chemicals and pharmaceuticals. By providing a comprehensive set of recommendations, guidance, and training resources, NAMWISE seeks to validate and implement NAMs effectively. The project adopts a definition of NAMs that excludes vertebrate-based data and models, focusing on in vitro approaches (including organoids and organ-on-chips), in silico methods, Adverse Outcome Pathways (AOP), and Integrated Approaches to Testing and Assessment (IATA).

NAMWISE

Org chart

Teams

Offices